Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-01-08 Sale |
2024-01-09 4:05 pm |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
15,000 | $43.33 | $650,000 | 143,057 (Indirect Direct) |
View |
2024-01-08 Sale |
2024-01-09 4:02 pm |
RxSight Inc. | RXST | Corley Jesse Anderson Director |
2,000 | $45.03 | $90,059 | 513,340 (Indirect Direct) |
View |
2024-01-02 Sale |
2024-01-03 4:11 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $39.24 | $392,409 | 97,498 (Indirect Direct) |
View |
2023-12-27 Sale |
2023-12-29 4:57 pm |
RxSight Inc. | RXST | Kurtz Ronald M MD President & CEO |
22,500 | $41.09 | $924,498 | 907,110 (Indirect Direct) |
View |
2023-12-22 Sale |
2023-12-26 4:11 pm |
RxSight Inc. | RXST | Weinberg Eric Chief Commercial Officer |
1,285 | $40 | $51,400 | 347,131 (Indirect Direct) |
View |
2023-12-22 Sale |
2023-12-26 4:10 pm |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
5,000 | $40 | $200,000 | 158,054 (Indirect Direct) |
View |
2023-12-18 Sale |
2023-12-20 6:07 pm |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
10,937 | $39.02 | $426,710 | 183,897 (Indirect Direct) |
View |
2023-12-15 Sale |
2023-12-19 8:14 pm |
RxSight Inc. | RXST | Weinberg Eric Chief Commercial Officer |
8,715 | $40.01 | $348,711 | 348,416 (Indirect Direct) |
View |
2023-12-15 Sale |
2023-12-18 7:09 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
40,000 | $39.33 | $1,573,310 | 107,498 (Indirect Direct) |
View |
2023-12-14 Sale |
2023-12-18 7:08 pm |
RxSight Inc. | RXST | Corley Jesse Anderson Director |
12,000 | $40.12 | $481,469 | 104,764 (Indirect Direct) |
View |
2023-12-14 Sale |
2023-12-18 7:07 pm |
RxSight Inc. | RXST | Kurtz Ronald M MD President & CEO |
40,000 | $39.7 | $1,588,186 | 929,610 (Indirect Direct) |
View |
2023-12-08 Sale |
2023-12-12 6:49 pm |
RxSight Inc. | RXST | Warner Robert Keith Director |
20,000 | $35.03 | $700,551 | 51,483 (Indirect Direct) |
View |
2023-11-28 Sale |
2023-11-30 7:32 pm |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
494,313 | $29.73 | $14,695,695 | 471,098 (Indirect Direct) |
View |
2023-11-14 Sale |
2023-11-16 7:31 pm |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
500,000 | $27.18 | $13,590,750 | 960,791 (Indirect Direct) |
View |
2023-09-07 Sale |
2023-09-11 6:15 pm |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
32,950 | $30.14 | $992,969 | 1,460,791 (Indirect Direct) |
View |
2023-08-29 Sale |
2023-08-29 5:10 pm |
RxSight Inc. | RXST | Maniar Shweta Director |
4,292 | $28.06 | $120,451 | 24,947 (Direct) |
View |
2023-08-25 Sale |
2023-08-28 7:44 pm |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
16,208 | $29.25 | $474,129 | 1,317,027 (Indirect Direct) |
View |
2023-08-17 Sale |
2023-08-18 4:08 pm |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
33,135 | $29.62 | $981,570 | 1,775,863 (Indirect Direct) |
View |
2023-02-10 Purchase |
2023-02-13 6:20 pm |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
480,000 | $12.5 | $6,000,000 | 2,997,321 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-01-08 Exercise |
2024-01-09 4:05 pm |
N/A N/A |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
15,000 | $15.08 | 143,057 (Direct) |
View |
2024-01-08 Exercise |
2024-01-09 4:05 pm |
N/A 2030-04-22 |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
15,000 | $0 | 143,057 (Direct) |
View |
2024-01-02 Exercise |
2024-01-03 4:11 pm |
N/A 2031-03-22 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $0 | 97,498 (Direct) |
View |
2024-01-02 Exercise |
2024-01-03 4:11 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $15.6 | 97,498 (Direct) |
View |
2023-12-22 Exercise |
2023-12-26 4:10 pm |
N/A N/A |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
5,000 | $15.08 | 158,054 (Direct) |
View |
2023-12-22 Exercise |
2023-12-26 4:10 pm |
N/A 2030-04-22 |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
5,000 | $0 | 158,054 (Direct) |
View |
2023-12-18 Exercise |
2023-12-20 6:07 pm |
N/A N/A |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
10,000 | $15.08 | 183,897 (Direct) |
View |
2023-12-18 Exercise |
2023-12-20 6:07 pm |
N/A N/A |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
937 | $4.13 | 183,897 (Direct) |
View |
2023-12-18 Exercise |
2023-12-20 6:07 pm |
2021-04-26 2027-04-25 |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
10,937 | $0 | 183,897 (Direct) |
View |
2023-12-15 Exercise |
2023-12-18 7:09 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
20,000 | $15.6 | 107,498 (Direct) |
View |
2023-12-15 Exercise |
2023-12-18 7:09 pm |
N/A 2031-03-22 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
20,000 | $0 | 107,498 (Direct) |
View |
2023-11-30 Other |
2023-11-30 7:32 pm |
N/A N/A |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
447,710 | $0 | 471,098 (Indirect) |
View |
2023-11-13 Other |
2023-11-15 6:12 pm |
N/A N/A |
RxSight Inc. | RXST | Corley Jesse Anderson Director |
134,213 | $0 | 661,553 (Indirect) |
View |
2023-08-24 Other |
2023-08-28 7:44 pm |
N/A N/A |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
268,686 | $0 | 1,317,027 (Indirect) |
View |
2023-08-17 Other |
2023-08-18 6:46 pm |
N/A N/A |
RxSight Inc. | RXST | LINK WILLIAM J PHD Director |
717,982 | $0 | 795,029 (Indirect) |
View |
2023-08-17 Other |
2023-08-18 6:45 pm |
N/A N/A |
RxSight Inc. | RXST | Corley Jesse Anderson Director |
82,654 | $0 | 631,598 (Direct) |
View |
2023-08-09 Other |
2023-08-11 4:13 pm |
N/A N/A |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
530,100 | $0 | 2,339,098 (Indirect) |
View |
2023-07-26 Exercise |
2023-07-27 4:44 pm |
N/A N/A |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
25,475 | $3.9254 | 43,514 (Direct) |
View |
2023-07-26 Exercise |
2023-07-27 4:44 pm |
2019-09-08 2025-10-27 |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
25,475 | $0 | 43,514 (Direct) |
View |
2023-06-14 Other |
2023-06-16 4:49 pm |
N/A N/A |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
268,761 | $0 | 1,829,259 (Indirect) |
View |
2023-06-01 Option Award |
2023-06-05 4:37 pm |
N/A N/A |
RxSight Inc. | RXST | Warner Robert Keith Director |
5,731 | $0 | 71,483 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:36 pm |
N/A N/A |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
5,731 | $0 | 2,539,037 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:35 pm |
N/A N/A |
RxSight Inc. | RXST | PALMISANO ROBERT J Director |
5,731 | $0 | 27,733 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:33 pm |
N/A N/A |
RxSight Inc. | RXST | Maniar Shweta Director |
5,731 | $0 | 29,239 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:32 pm |
N/A N/A |
RxSight Inc. | RXST | LINK WILLIAM J PHD Director |
5,731 | $0 | 747,313 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:30 pm |
N/A N/A |
RxSight Inc. | RXST | Fountain Tamara Director |
5,731 | $0 | 29,239 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:29 pm |
N/A N/A |
RxSight Inc. | RXST | Corley Jesse Anderson Director |
5,731 | $0 | 466,290 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:27 pm |
N/A N/A |
RxSight Inc. | RXST | Andrews Julie Director |
5,731 | $0 | 43,358 (Direct) |
View |
2023-05-26 Other |
2023-05-31 6:09 pm |
N/A N/A |
RxSight Inc. | RXST | Tammenoms Bakker Juliet Director |
530,285 | $0 | 3,063,591 (Indirect) |
View |
2023-05-11 Other |
2023-05-12 3:15 pm |
N/A N/A |
RxSight Inc. | RXST | LINK WILLIAM J PHD Director |
357,105 | $0 | 1,098,687 (Indirect) |
View |
2023-03-09 Option Award |
2023-03-10 4:14 pm |
N/A 2033-03-09 |
RxSight Inc. | RXST | Goldshleger Ilya Chief Operating Officer |
120,000 | $0 | 120,000 (Direct) |
View |
2023-03-09 Option Award |
2023-03-10 4:13 pm |
N/A 2033-03-09 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
2023-03-09 Option Award |
2023-03-10 4:11 pm |
N/A 2033-03-09 |
RxSight Inc. | RXST | Weinberg Eric Chief Commercial Officer |
95,000 | $0 | 95,000 (Direct) |
View |
2023-03-09 Option Award |
2023-03-10 4:10 pm |
N/A 2033-03-09 |
RxSight Inc. | RXST | Kurtz Ronald M MD President & CEO |
200,000 | $0 | 200,000 (Direct) |
View |
2023-02-10 Option Award |
2023-02-13 6:19 pm |
N/A N/A |
RxSight Inc. | RXST | Kurtz Ronald M MD President & CEO |
40,000 | $12.5 | 969,610 (Direct) |
View |